Global Mechanical Thrombectomy Devices Market

Report ID : 1183 | Published : 2021-07-29 | Pages: 190 | Format: PDF/EXCEL

A Tissue Plasminogen Activator (tPA) or clot-busting drug was the only effective and proven therapy for ischemic strokes. Mechanical thrombectomy is the novel treatment option for patients suffering from ischemic stroke. Mechanical thrombectomy is an advanced treatment for stroke that eradicates blood clots from the brain’s large blood vessels. A significant percentage of the acute stroke patient populace is entitled to treatment with thrombolysis. In 2018, according to the NHS England commissionary policy, approximately 12% of all individuals with stroke were qualified for mechanical thrombectomy treatment. The rising prevalence of stroke and growing demand for effective treatment are expected to propel the growth of these devices over the forecast period.


The Mechanical Thrombectomy Devices Market is a segment based on product type, application, end-user, and geography. Based on product type, the global mechanical thrombectomy devices market is segmented into stent retriever devices, coil retriever devices, aspiration devices, and others (ultrasound-based devices). Stryker’s Merci Retriever system and Penumbra’s Penumbra Aspiration device are the first generations mechanical thrombectomy devices. Moreover, the growing FDA approvals and ongoing research activities are expected to propel the growth of the market in the coming years. Stent retriever devices are estimated to account for the significant share in the global mechanical thrombectomy devices market in 2019, owing to the growing use of these devices in past years. Moreover, growing strategic activities among the key players operating in the market are projected to propel the growth of the market significantly during the estimated timeframe.
Based on application, the market is segmented into the stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), arteriovenous fistula (AVF), peripheral arterial disease (PAD), hemodialysis treatments, and others. By end-user, the global mechanical thrombectomy devices market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and academic & research institutes. In 2019, the hospitals accounted for a significant share in the global mechanical thrombectomy devices market. The presence of a vast number of multispecialty hospitals enhanced reimbursement policies for neurovascular and cardiovascular disorders, and availability of well-trained health care specialists are contributing towards the high share of hospitals in the global market. The ambulatory surgical centers are expected to register high CAGR during the forecast period. The growing demand for invasive surgical procedures and the rising number of ambulatory surgical centers are propelling the growth of the segment in the global market.
Based on geography, the Global Mechanical Thrombectomy Devices Market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In 2019, North America is accounted for a significant share in the global mechanical thrombectomy devices market. The presence of large numbers of companies operating in the market, high adoption of technically advanced products, well-established healthcare infrastructure and are some of the significant factors contributing to the high share of the market in the region. Additionally, growing demand for minimally invasive surgeries in the area is expected to propel the growth of the North America mechanical thrombectomy devices market over the estimated timeframe.
Some of the market players leading the Global Mechanical Thrombectomy Devices Market include Boston Scientific Corporation, Straub Medical AG, AngioDynamics, Acandis GmbH, NIPRO, Medtronic, MicroVention, Inc., Stryker Corporation, Phenox GmbH, Penumbra, Inc., Balt Extrusion, Medrad Inc. (Bayer HealthCare LLC), Johnson & Johnson, Rapid Medical Inc., and Anaconda Biomed SL among others.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Mechanical Thrombectomy Devices Market Snapshot

Chapter 4. Global Mechanical Thrombectomy Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Market Dynamics - Drivers

4.3. Challenges/Restraints

4.4. Market Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Installed Base - 2019

4.6.1. AngioJe Coronary Thrombectomy System

4.6.2. AngioJet Peripheral Thrombectomy System

4.6.3. CLEANER Rotational Thrombectomy System

4.6.4. ClotTriever Thrombectomy System

4.6.5. EkoSonic Endovascular System

4.7. Global Epidemiology Analysis by Key Country 2019

4.7.1. Stroke

4.7.2. Deep Vein Thrombosis (DVT)

4.7.3. Pulmonary Embolism (PE)

4.7.4. Arteriovenous fistula (AVF)

4.7.5. Peripheral Arterial Disease (PAD)

4.7.6. Dialysis (AV Fistula and AV Graft)

4.7.7. Percutaneous coronary intervention (PCI)

Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis

5.1. Product Type & Market Share, 2018 & 2028

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2018 to 2028 for the following Product Type:

5.2.1. Coil Retriever Devices

5.2.2. Stent Retriever Devices

5.2.3. Aspiration Devices

5.2.4. Manual Thrombectomy Devices

5.2.5. Others (Ultrasound Based Devices)

Chapter 6. Mechanical Thrombectomy Devices Market Segmentation 2: Application Estimates & Trend Analysis

6.1. Application Analysis & Market Share, 2018 & 2028

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2018 to 2028 for the following Application:

6.2.1. Stroke

6.2.2. Deep Vein Thrombosis (DVT)

6.2.3. Pulmonary Embolism (PE)

6.2.4. Arteriovenous fistula (AVF)

6.2.5. Peripheral Arterial Disease (PAD)

6.2.6. Haemodialysis Treatments

6.2.7. Percutaneous coronary intervention (PCI)

6.2.8. Others

Chapter 7. Mechanical Thrombectomy Devices Market Segmentation 2: End-user Estimates & Trend Analysis

7.1. End-user Analysis & Market Share, 2018 & 2028

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2018 to 2028 for the following End-user:

7.2.1. Hospitals

7.2.2. Ambulatory Surgical Centers

7.2.3. Specialty Clinics

7.2.4. Academic & Research Institutes

Chapter 8. Mechanical Thrombectomy Devices Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

8.1.2. North America Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application Type, 2018-2028

8.1.3. North America Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2018-2028

8.1.4. North America Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2018-2028

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

8.2.2. Europe Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application Type, 2018-2028

8.2.3. Europe Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2018-2028

8.2.4. Europe Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2018-2028

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

8.3.2. Asia Pacific Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application Type, 2018-2028

8.3.3. Asia Pacific Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2018-2028

8.3.4. Asia Pacific Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2018-2028

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

8.4.2. Latin America Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application Type, 2018-2028

8.4.3. Latin America Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2018-2028

8.4.4. Latin America Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2018-2028

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

8.5.2. MEA Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application Type, 2018-2028

8.5.3. MEA Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2018-2028

8.5.4. MEA revenue Mechanical Thrombectomy Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2018-2028

8.5.4.1. South Africa

8.5.4.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Boston Scientific Corporation

9.2.1.1. Company Overview

9.2.1.2. Financials

9.2.1.3. Product portfolio

9.2.1.4. Business strategy & Recent developments

9.2.2. Straub Medical AG

9.2.3. AngioDynamics

9.2.4. Acandis GmbH

9.2.5. NIPRO

9.2.6. Medtronic

9.2.7. MicroVention, Inc.

9.2.8. Stryker Corporation

9.2.9. Phenox GmbH

9.2.10. Penumbra, Inc.

9.2.11. Balt Extrusion

9.2.12. Medrad Inc. (Bayer HealthCare LLC)

9.2.13. Johnson & Johnson

9.2.14. Rapid Medical Inc.

9.2.15. Anaconda Biomed SL

9.2.16. Imperative Care Inc.

9.2.17. Vascular Medcure, Inc.

Global Mechanical Thrombectomy Devices Market Segmentation

Global Mechanical Thrombectomy Devices Market Outlook (Value (US$ Mn) & Volume (no. of units), 2019 – 2030) By Product Type

  • Coil Retriever Devices
  • Stent Retriever Devices
  • Aspiration Devices
  • Others (Ultrasound Based Devices)

Global Mechanical Thrombectomy Devices Market Outlook (Value (US$ Mn) & Volume (no. of units), 2019 – 2030) By Application

  • Stroke
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Arteriovenous fistula (AVF)
  • Peripheral Arterial Disease (PAD)
  • Haemodialysis Treatments
  • Others

Global Mechanical Thrombectomy Devices Market Outlook (Value (US$ Mn), 2019 – 2030) By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Academic & Research Institutes

Global Mechanical Thrombectomy Devices Market Outlook (Value (US$ Mn) & Volume (no. of units), 2019 – 2030) By Region

  • Europe
    • Germany
    • Poland
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients